Filtered By:
Source: Neurology
Condition: Ischemic Stroke

This page shows you your search results in order of date. This is page number 14.

Order by Relevance | Date

Total 1519 results found since Jan 2013.

Rapidly improving neurological deficit of stroke; case series in Academic institute, KAUH, Jeddah (P4.283)
Conclusions:Rapidly improving patient represent a challenge to whether tPA should be given. However, the good outcome with thrombolytic therapy observed in our study, will hopfuly support the decision to treat.Study Supported by: nonDisclosure: Dr. khoja has nothing to disclose. Dr. Alshaer has nothing to disclose. Dr. al-Turkistani has nothing to disclose. Dr. Al-Mekhalfi has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: khoja, a., Al-Shaer, D., al-Turkistani, a., Al-Mekhalfi, M. Tags: Thrombolysis and Acute Evaluation in Ischemic Stroke Source Type: research

Barriers to thrombolysis in a tertiary care institute in eastern India (P4.284)
Conclusions:Thus this study highlights the various lacunaes we have for thrombolysis and gives us scope to further improve and increase its rate.Disclosure: Dr. Chatterjee has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Chatterjee, A. Tags: Thrombolysis and Acute Evaluation in Ischemic Stroke Source Type: research

Resident door to needle Analysis: A retrospective Chart rEview (RACE) (P4.285)
Conclusions:Recognition and token awards for neurology residents can lead to shorter DTN times which could, in turn, improve outcomes in AIS. However, this approach requires a continued review of diagnostic accuracy and adverse events to ensure quality of care is not compromised for the sake of speed.Disclosure: Dr. Patel has nothing to disclose. Dr. Mehta has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Patel, N., Mehta, S. Tags: Thrombolysis and Acute Evaluation in Ischemic Stroke Source Type: research

High values of baseline and 24-hour Mean Arterial Pressure are associated with lower chance of early neurological improvement in acute stroke patients treated with thrombolysis (P4.286)
Conclusions:High baseline and 24-hr MAP values are associated with lower chance of achieving ENI after IV thrombolysis. Further studies are needed to better understand whether acute BP dysregulation can influence different clinical courses in the early phase of IV thrombolysis.Disclosure: Dr. Lorenzano has nothing to disclose. Dr. Caselli has nothing to disclose. Dr. Zingaro has nothing to disclose. Dr. Orlando has nothing to disclose. Dr. Toni has received research support from Bayer, Medtronic, and Boehriger Ingelheim.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Lorenzano, S., Caselli, M. C., Zingaro, A., Orlando, F., Toni, D. Tags: Thrombolysis and Acute Evaluation in Ischemic Stroke Source Type: research

Can admission Brain Natriuretic Peptide level predict outcome after intravenous thrombolysis in acute ischemic stroke? (P4.287)
Conclusions:Elevated BNP level was not found to be an independent marker of poor outcome in acute ischemic stroke patients following intravenous thrombolysis.Disclosure: Dr. Gupta has nothing to disclose. Dr. Finlay has nothing to disclose. Dr. Jacob has nothing to disclose. Dr. Raina has nothing to disclose. Dr. Lee has nothing to disclose. Dr. Hinduja has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Gupta, H., Finlay, C., Jacob, S., Raina, S., Lee, R., Hinduja, A. Tags: Thrombolysis and Acute Evaluation in Ischemic Stroke Source Type: research

Early Decompressive Hemicraniectomy for Malignant Middle Cerebral Artery Infarction: A single centre retrospective study (P4.290)
Conclusions:Early decompression craniectomy, especially in right MCA ischemic stroke is associated with better favorable functional outcome at 6 months.Disclosure: Dr. Bharatendu has nothing to disclose. Dr. Chong has nothing to disclose. Dr. Paliwal has nothing to disclose. Dr. Teoh has nothing to disclose. Dr. Yeo has nothing to disclose. Dr. Seet has nothing to disclose. Dr. Chan has nothing to disclose. Dr. YEO has nothing to disclose. Dr. LWIN has nothing to disclose. Dr. NING has nothing to disclose. Dr. SHARMA has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Bharatendu, C., Chong, Y. F. V., Paliwal, P., Teoh, H. L., Yeo, L., Seet, R., Chan, B., YEO, T. T., LWIN, S., NING, C., SHARMA, V. K. Tags: In-Hospital Stroke Care Source Type: research

Hemorrhagic transformation of ischemic strokes: risk factors and prognostic implications (P4.291)
Conclusions:IV thrombolytic therapy, cardioembolic stroke and prior warfarin use were independent predictors of HT. PH2 was associated with increased risk of poor outcome at around 90 days and mortality at 90 days and 5 years.Disclosure: Dr. Cheung has nothing to disclose. Dr. Chan has nothing to disclose. Dr. Lee has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Cheung, R., Chan, K. H., Lee, R. Tags: In-Hospital Stroke Care Source Type: research

Seizure Incidence in Ischemic Stroke Patients Treated with and without tPA: A Single Center Study (P4.292)
Conclusions:Treatment with tPA reduces the incidence of early onset seizures in stroke patients. Further studies would be needed to clarify the effect of tPA administration on the incidence of seizures after 24 hours.Disclosure: Dr. Vaidyanathan has nothing to disclose. Dr. Hawkins has nothing to disclose. Dr. Morris has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Vaidyanathan, V., Hawkins, A., Morris, H. Tags: In-Hospital Stroke Care Source Type: research

Pulmonary embolism in acute ischaemic stroke (p4.293)
Conclusions:PE was observed in 0.32% of AIS and associated with high rates of death and disability. CTA stroke protocol images from aortic arch to vertex allows visualization of upper pulmonary arteries and detection PE in AIS.Disclosure: Dr. Eswaradass has nothing to disclose. Dr. Dey has nothing to disclose. Dr. Singh has nothing to disclose. Dr. Hill has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Eswaradass, P. V., Dey, S., Singh, D., Hill, M. Tags: In-Hospital Stroke Care Source Type: research

Early Carotid Revascularization Reduces Readmission for Recurrent Ischemic Stroke in Acute Ischemic Stroke Patients: Analysis of United States Nationwide Readmissions Database (P4.294)
Conclusions:Patients with ischemic stroke undergoing carotid revascularization during the initial hospitalization have significantly lower risk of readmission related to another ischemic strokeDisclosure: Dr. Chaudhry has nothing to disclose. Dr. Gheith has nothing to disclose. Dr. Gu has nothing to disclose. Dr. Afzal has nothing to disclose. Dr. Rahman has nothing to disclose. Dr. Riaz has nothing to disclose. Dr. Sachdeva has nothing to disclose. Dr. Sattar has nothing to disclose. Dr. Razak has nothing to disclose. Dr. Qureshi has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Chaudhry, S., Gheith, T., Gu, S., Afzal, M.-R., Rahman, H., Riaz, A., Sachdeva, G., Sattar, A., Razak, A., Qureshi, A. Tags: In-Hospital Stroke Care Source Type: research

Is Transesophageal Echocardiogram Associated with Neurological Worsening after Ischemic Stroke? (P4.295)
Conclusions:TEE does not appear to convey an increased risk for neurological worsening during the acute phase of stroke. In patients who underwent TEE, timing of their NWE did not significantly affect outcomes.Disclosure: Dr. Attenhofer has nothing to disclose. Dr. Monlezun, Jr has nothing to disclose. Dr. Schluter has nothing to disclose. Dr. Samai has nothing to disclose. Dr. Navalkele has nothing to disclose. Dr. Martin-Schild has received personal compensation for activities with Genentech as a speaker.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Attenhofer, K., Monlezun, D., Schluter, L., Samai, A., Navalkele, D., Martin-Schild, S. Tags: In-Hospital Stroke Care Source Type: research

Recent Nationwide Trends in Transcranial Doppler Utilization During Acute Ischemic Stroke Hospitalizations (P4.296)
Conclusions:Over the last decade there has been a slight but steady decrease in the use of TCD during AIS hospitalizations in the US. Future studies should examine the cost-utility of TCD, especially with the advent of endovascular stroke treatment systems.Disclosure: Dr. Liu has nothing to disclose. Dr. Lunagariya has nothing to disclose. Dr. Patel has nothing to disclose. Dr. Patel has nothing to disclose. Dr. Feng has nothing to disclose. Dr. Ovbiagele has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Liu, Y., Lunagariya, A., Patel, U., Patel, A., Feng, W., Ovbiagele, B. Tags: In-Hospital Stroke Care Source Type: research

Association of splenic contraction and development of SIRS after acute ischemic stroke. (P4.297)
Conclusions:Based on our initial evaluation, SC detected within 24 hrs of stroke onset is not associated with SIRS suggesting that the relationship between the two may be more complicated in humans. Consistent with prior studies, however, SIRS is associated with worse outcome. Further studies and additional time points are necessary to further clarify the role of the spleen in the development of SIRS in stroke patients.Disclosure: Dr. Zha has nothing to disclose. Dr. Tippinayani has nothing to disclose. Dr. Randhawa has nothing to disclose. Dr. Vahidy has nothing to disclose. Dr. Savitz has received research support from the NIH.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Zha, A., Tippinayani, B., Randhawa, J., Vahidy, F., Savitz, S. Tags: In-Hospital Stroke Care Source Type: research

Analysis of current clinical practice on initiation of anticoagulation in patients with acute ischemic stroke. (P4.298)
Conclusions:Physicians with a subspecialty in vascular neurology, those with more years of experience in practice, and those practicing at academic institutions tended to initiate anticoagulation later.Disclosure: Dr. Olivas has nothing to disclose. Dr. Ajani has nothing to disclose. Dr. Yao has nothing to disclose. Dr. Sangha has nothing to disclose.
Source: Neurology - April 17, 2017 Category: Neurology Authors: Olivas, E., Ajani, Z., Yao, J., Sangha, N. Tags: In-Hospital Stroke Care Source Type: research

Stroke versus non-stroke neurological complications after cardiac transplant (P4.299)
Conclusions:Neurological complications after CT in our population reach nearly a quarter of patients, similar to or even lower than in previous studies.4.3% of patients developed stroke, ischemic subtype.Pre- and perioperative variables do not differ between both groups, except from ischemic cardiomyopathy as the cause of heart failure being it more frequent in the stroke group.Disclosure: Dr. Vazquez has nothing to disclose. Dr. Thomson has nothing to disclose. Dr. Molina Melendres has nothing to disclose. Dr. Nadile has nothing to disclose. Dr. Gonzalez Toledo has nothing to disclose. Dr. Claverie has nothing to disclose...
Source: Neurology - April 17, 2017 Category: Neurology Authors: Vazquez, G., Thomson, A., Melendres, J. M., Nadile, D., Toledo, M. E. G., Claverie, C. S., Thomson, A., Peradejordi, M., Couto, B., Favaloro, L. E., Favaloro, R., Bertolotti, A., Klein, F. Tags: In-Hospital Stroke Care Source Type: research